4 Experimental Ebola Therapies Approved for Use in Congo

Share this content:
4 Experimental Ebola Therapies Approved for Use in Congo
4 Experimental Ebola Therapies Approved for Use in Congo

WEDNESDAY, Aug. 22, 2018 (HealthDay News) -- Four more experimental treatments for Ebola virus have been approved by the Congo health ministry for use in an outbreak of the deadly infectious disease in the country's northeast.

The treatments are ZMapp, Remdesivir, Favipiravir, and Regn3450 - 3471 - 3479. On Aug. 11, health officials began using the experimental treatment mAb114 on 10 patients, and the ministry says they are doing well, the Associated Press reported.

The most recent Ebola outbreak in Congo was declared in Mangina in North Kivu province on Aug. 1. There have been 75 confirmed Ebola cases and 27 probable ones. Of 59 reported deaths, 32 have been confirmed as Ebola, according to the health ministry.

The ministry said that since Aug. 8, more than 1,600 people have been vaccinated in Mabalako and Beni in North Kivu province and in Mandima in Ituri province, the AP reported.

AP News Article
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »